Northwell Health, START collaborate to increase patient access to research

Thyme Care closes $95M Series C to advance optimization of care, navigation

Thyme Care announced the close of a $95 million capital raise. With $55 million in equity funding, Thyme Care welcomes new investor Concord Health Partners with participation from all existing investors, including CVS Health Ventures, Town Hall Ventures, a16z Bio + Health, AlleyCorp, Echo Health Ventures, Frist Cressey Ventures, and Foresite Capital.

July 19, 2024

Vol.50 No.29

In Brief

Chika Madu named director of Northwell’s Staten Island University Hospital Florina Cancer Center

Chika Madu was named director of Staten Island University Hospital Florina Cancer Center, which is part of the Northwell Health Cancer Institute.

June 21, 2024

Vol.50 No.25

NCI Director's Report

NCI faces prospect of an 11% cut in FY25—another setback in a period of tight budgets and sliding paylines

After a year of lean appropriations, NCI is looking at what threatens to be a budgetary cataclysm—a potential 10-11% cut to the Labor-HHS spending bill in fiscal year 2025.

June 14, 2024

Vol.50 No.24

By Matthew Bin Han Ong

In Brief

Oana Danciu named Big Ten CRC steering committee chair

Oana Danciu, associate director for clinical research at the University of Illinois Cancer Center, was appointed by the Big Ten Cancer Research Consortium as chair of its steering committee.

June 14, 2024

Vol.50 No.24

Conversation with The Cancer Letter

ACS, ASCO combine online patient information services

The American Cancer Society and the American Society of Clinical Oncology have combined their cancer information resources, which will be available at no cost to the public on cancer.org. The collaboration, which combines the two organizations’ sites—ACS’s cancer.org and ASCO’s cancer.net—was announced at the 2024 ASCO Annual Meeting in Chicago May 1. Cancer.org is now...

Refocusing cancer R&D for greater impact: Addressing gaps in disparities and access

While cutting-edge therapies grace headlines, the impact of breakthrough research remains limited due to patient access, affordability, and adherence.

May 31, 2024

Vol.50 No.22

By Alice L. Pomponio